News

To accompany our recent post-colonoscopy colorectal cancer paper, our Patient-Public Group have written an opinion piece for the British Medical Journal. They explain the importance of deriving intelligence from healthcare data. As they say, “Being able to access and analyse the data is good, however it is only of benefit if it can be turned…
We have a new paper in the British Medical Journal! It compares risk-adjusted 3-year post-colonoscopy colorectal cancer (PCCRC) rates across all colonoscopy providers in England. Colonoscopies were divided into three time periods: 2005 to 2007, 2008 to 2010 and 2011 to 2013. Please read the University of Leeds press release. A plain language summary is…
Two members of our Patient-Public Group tell their stories on the Bowel Cancer UK website. Pete Wheatstone talks about the shock of being diagnosed with stage 3 bowel cancer in 2014 and Barbara Hibbert shares her experiences of living with a terminal diagnosis. Our BCI UK Patient and Public Group is made up of patient…
Would you like to be involved in bowel cancer research? Our research aims to underpin the prevention of bowel cancer and improve the care of those with the disease. This involves linking information from many sources including cancer registration and hospital care in order to better understand the full patient pathway. Funded by Cancer Research…
This coming Saturday one of our research fellows will be presenting at the twenty-sixth annual meeting of the European Surgical Association in Madrid. In session VI Dr. Hayley Fenton will be giving a talk entitled “Variation in the use of resection for colorectal cancer liver metastases”. The meeting brings together leading surgeons and scientists to…
We are delighted to announce the appointment of Elizabeth Lemmon to the role of health economist within CORECT-R. Elizabeth will work on both Scottish and English datasets, and will also coordinate the health economics work stream in conjunction with Dr Peter Hall. Elizabeth recently completed her PhD studies in Economics at the University of Stirling,…
The Edinburgh CORECT-R team have successfully applied to the Scottish Public Benefit and Privacy Panel for Health for bowel cancer data relating to Scottish patients. The focus of this initial application is our health economics workstream. Given rising healthcare costs, and the financial pressures on the NHS, information on the cost of cancer is keenly…
We have a Data Sharing Contract (ODR1516_369) with Public Health England (PHE) and use de-personalised data for bowel cancer research. In recent months our Patient-Public Group has worked with PHE on the wording that goes into publications and reports to acknowledge the source of the data. This has produced a simple yet comprehensive acknowledgement: “This…
The Health Foundation, in collaboration with Professor Sir Mike Richards, has published an assessment of efforts to improve cancer services in England over almost two decades. It is titled “Unfinished business. An assessment of the national approach to improving cancer services in England 1995–2015”. It contains quotes from BCI UK’s leader, Professor Eva Morris, and…
Professor Eva Morris is speaking at the 2018 NCRI Cancer Conference which is being held in Glasgow this week. Professor Morris, along with experts from Health Data Research UK, The University of Edinburgh and The University of Bristol, will be providing an overview of the use of data science in cancer risk assessment, prevention, screening, early diagnosis…